|
|
.
See Category: Neoplasms
See Header: Malignant neoplasm of lower-inner quadrant of breast, female
ICD-10 (CM) Code and Descriptor
|
C50.319 |
Malignant neoplasm of lower-inner quadrant of unspecified female breast
Diagnosis Valid for Female Patient Only
|
C50319 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 45.54%
|
24.55%
|
10.91%
|
5.21%
|
4.55%
|
2.73%
|
2.07%
|
0.91%
|
1.16%
|
0.83%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C50.319*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
80053
|
COMPREHEN METABOLIC PANEL |
313
|
313
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
304
|
304
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
281
|
281
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
242
|
242
|
|
86300
|
IMMUNOASSAY TUMOR CA 15-3 |
116
|
122
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
40
|
40
|
|
97140
|
MANUAL THERAPY 1/> REGIONS |
38
|
134
|
|
96402
|
CHEMO HORMON ANTINEOPL SQ/IM |
35
|
39
|
|
82728
|
ASSAY OF FERRITIN |
34
|
34
|
|
82306
|
VITAMIN D 25 HYDROXY |
33
|
33
|
|
83540
|
ASSAY OF IRON |
31
|
31
|
|
77385
|
NTSTY MODUL RAD TX DLVR SMPL |
27
|
27
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
26
|
26
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
25
|
25
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
25
|
25
|
|
J9395
|
INJECTION, FULVESTRANT |
24
|
480
|
|
71260
|
CT THORAX DX C+ |
23
|
23
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
23
|
1,905
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
23
|
23
|
|
77066
|
DX MAMMO INCL CAD BI |
21
|
21
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C50.319 related to the following DRG Codes:
582-583
597-599
|
